Literature DB >> 24337946

Substantia nigra in Parkinson's disease: a multimodal MRI comparison between early and advanced stages of the disease.

Domenico Aquino1, Valeria Contarino, Alberto Albanese, Ludovico Minati, Laura Farina, Marina Grisoli, Luigi Romita, Antonio Emanuele Elia, Antonio Elia, Maria Grazia Bruzzone, Luisa Chiapparini.   

Abstract

This study focused on the substantia nigra (SN) in Parkinson's disease (PD). We measured its area and volume, mean diffusivity (MD), fractional anisotropy (FA) and iron concentration in early and late PD and correlated the values with clinical scores. Twenty-two early PD (EPD), 20 late PD (LPD) and 20 healthy subjects (age 64.7 ± 4.9, 60.5 ± 6.1, and 61 ± 7.2 years, respectively) underwent 1.5 T MR imaging with double-TI-IR T1-weighted, T2*-weighted and diffusion tensor imaging scans. Relative SN area, MD, FA and R2* were measured in ROIs traced on SN. Correlation with Unified Parkinson Disease Rating Scale (UPDRS) scores was assessed. In LPD, the SN area was significantly reduced with respect to EPD (p = 0.04) and control subjects (p < 0.001). In EPD, the SN area was also significantly smaller than in controls (p = 0.006). Similarly, the SN volume significantly differed between LPD and controls (p = 0.001) and between EPD and LPD (p = 0.049), while no significant differences were found between controls and EPD. Both SN area (r = 0.47, p = 0.004) and volume (r = 0.46, p = 0.005) correlated with UPDRS scores. At 1.5 T, SN morphological measurements were sensitive to early PD changes and able to track the disease progression, while MD and FA measures and relaxometry did not provide significant results.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24337946     DOI: 10.1007/s10072-013-1595-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  29 in total

1.  Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects.

Authors:  Domenico Aquino; Alberto Bizzi; Marina Grisoli; Barbara Garavaglia; Maria Grazia Bruzzone; Nardo Nardocci; Mario Savoiardo; Luisa Chiapparini
Journal:  Radiology       Date:  2009-07       Impact factor: 11.105

Review 2.  Milestones in Parkinson's disease--clinical and pathologic features.

Authors:  Glenda Halliday; Andrew Lees; Matthew Stern
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

3.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  Inversion recovery MRI in idiopathic Parkinson disease is a very sensitive tool to assess neurodegeneration in the substantia nigra: preliminary investigation.

Authors:  Ulrich Raff; Michael Hutchinson; Gonzalo M Rojas; Isidro Huete
Journal:  Acad Radiol       Date:  2006-06       Impact factor: 3.173

6.  Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson's disease.

Authors:  C B Carroll; M-L Zeissler; N Chadborn; K Gibson; G Williams; J P Zajicek; K E Morrison; C O Hanemann
Journal:  Neurochem Int       Date:  2011-06-06       Impact factor: 3.921

7.  White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study.

Authors:  G Gattellaro; L Minati; M Grisoli; C Mariani; F Carella; M Osio; E Ciceri; A Albanese; M G Bruzzone
Journal:  AJNR Am J Neuroradiol       Date:  2009-04-02       Impact factor: 3.825

8.  Case control study of diffusion tensor imaging in Parkinson's disease.

Authors:  L-L Chan; H Rumpel; K Yap; E Lee; H-V Loo; G-L Ho; S Fook-Chong; Y Yuen; E-K Tan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-07-05       Impact factor: 10.154

9.  Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.

Authors:  R B Innis; J P Seibyl; B E Scanley; M Laruelle; A Abi-Dargham; E Wallace; R M Baldwin; Y Zea-Ponce; S Zoghbi; S Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

10.  Aging of subcortical nuclei: microstructural, mineralization and atrophy modifications measured in vivo using MRI.

Authors:  Andrea Cherubini; Patrice Péran; Carlo Caltagirone; Umberto Sabatini; Gianfranco Spalletta
Journal:  Neuroimage       Date:  2009-06-21       Impact factor: 6.556

View more
  28 in total

1.  Investigation of Apparent Diffusion Coefficient from Ultra-high b-Values in Parkinson's Disease.

Authors:  Ling Xueying; Zhang Zhongping; Zhao Zhoushe; Guo Li; Tang Yongjin; Shi Changzheng; Zhou Zhifeng; Chen Peihao; Xu Hao; Huang Li
Journal:  Eur Radiol       Date:  2015-03-07       Impact factor: 5.315

2.  R2* Map by IDEAL IQ for Acute Cerebral Infarction: Compared with Susceptibility Vessel Sign on T2*-Weighted Imaging.

Authors:  Yuki Shinohara; Ayumi Kato; Eijiro Yamashita; Toshihide Ogawa
Journal:  Yonago Acta Med       Date:  2016-09-12       Impact factor: 1.641

Review 3.  The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1.

Authors:  T C Booth; M Nathan; A D Waldman; A-M Quigley; A H Schapira; J Buscombe
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-05       Impact factor: 3.825

Review 4.  Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  David Devos; Z Ioav Cabantchik; Caroline Moreau; Véronique Danel; Laura Mahoney-Sanchez; Hind Bouchaoui; Flore Gouel; Anne-Sophie Rolland; James A Duce; Jean-Christophe Devedjian
Journal:  J Neural Transm (Vienna)       Date:  2020-01-07       Impact factor: 3.575

5.  Usefulness of R2* maps generated by iterative decomposition of water and fat with echo asymmetry and least-squares estimation quantitation sequence for cerebral artery dissection.

Authors:  Ayumi Kato; Yuki Shinohara; Eijiro Yamashita; Shinya Fujii; Fuminori Miyoshi; Keita Kuya; Toshihide Ogawa
Journal:  Neuroradiology       Date:  2015-06-13       Impact factor: 2.804

6.  A multicontrast approach for comprehensive imaging of substantia nigra.

Authors:  Jason Langley; Daniel E Huddleston; Xiangchuan Chen; Jan Sedlacik; Nishant Zachariah; Xiaoping Hu
Journal:  Neuroimage       Date:  2015-02-28       Impact factor: 6.556

Review 7.  Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Authors:  Beatrice Heim; Florian Krismer; Roberto De Marzi; Klaus Seppi
Journal:  J Neural Transm (Vienna)       Date:  2017-04-04       Impact factor: 3.575

Review 8.  Neuroimaging of Parkinson's disease: Expanding views.

Authors:  Carol P Weingarten; Mark H Sundman; Patrick Hickey; Nan-kuei Chen
Journal:  Neurosci Biobehav Rev       Date:  2015-09-26       Impact factor: 8.989

9.  Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited.

Authors:  Jason Langley; Daniel E Huddleston; Michael Merritt; Xiangchuan Chen; Rebecca McMurray; Michael Silver; Stewart A Factor; Xiaoping Hu
Journal:  Hum Brain Mapp       Date:  2016-03-29       Impact factor: 5.038

10.  Pool size ratio of the substantia nigra in Parkinson's disease derived from two different quantitative magnetization transfer approaches.

Authors:  Paula Trujillo; Paul E Summers; Alex K Smith; Seth A Smith; Luca T Mainardi; Sergio Cerutti; Daniel O Claassen; Antonella Costa
Journal:  Neuroradiology       Date:  2017-10-06       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.